Ensign Peak Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$115K Hold
4,115
﹤0.01% 1577
2026
Q1
$117K Hold
4,115
﹤0.01% 1523
2025
Q4
$163K Sell
4,115
-13,000
-76% -$477K ﹤0.01% 1410
2025
Q3
$603K Sell
17,115
-5,950
-26% -$205K ﹤0.01% 1306
2025
Q2
$756K Hold
23,065
﹤0.01% 1398
2025
Q1
$744K Hold
23,065
﹤0.01% 1414
2024
Q4
$705K Hold
23,065
﹤0.01% 1498
2024
Q3
$647K Hold
23,065
﹤0.01% 1537
2024
Q2
$525K Buy
23,065
+2,550
+12% +$58.9K ﹤0.01% 1587
2024
Q1
$624K Sell
20,515
-1,035
-5% -$34.7K ﹤0.01% 1570
2023
Q4
$769K Buy
21,550
+150
+0.7% +$5.58K ﹤0.01% 1522
2023
Q3
$937K Hold
21,400
﹤0.01% 1246
2023
Q2
$1.06M Hold
21,400
﹤0.01% 1212
2023
Q1
$887K Hold
21,400
﹤0.01% 1335
2022
Q4
$950K Buy
21,400
+14,150
+195% +$591K ﹤0.01% 1196
2022
Q3
$283K Buy
7,250
+3,780
+109% +$173K ﹤0.01% 1738
2022
Q2
$142K Hold
3,470
﹤0.01% 1891
2022
Q1
$228K Buy
3,470
+550
+19% +$35.6K ﹤0.01% 1844
2021
Q4
$203K Buy
+2,920
New +$212K ﹤0.01% 1923

Other funds holding ATRC

Ensign Peak Advisors's ATRC Position: Q2 2026 in Review

Ensign Peak Advisors held its AtriCure (ATRC) position steady in Q2 2026 at 4,115 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #1577.

Ensign Peak Advisors first reported a position in ATRC in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.06M in Q2 2023. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Ensign Peak Advisors held 4,115 shares of AtriCure worth $115K as of Q2 2026.
  • Ensign Peak Advisors left its AtriCure share count unchanged in Q2 2026.
  • AtriCure made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1577 holding.
  • Ensign Peak Advisors first reported a position in AtriCure in Q4 2021 and has held it in 19 quarters since.
  • Ensign Peak Advisors's AtriCure position peaked at $1.06M in Q2 2023.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.